Hangzhou Arcvideo Technology Co.Ltd(688039) shareholders plan to reduce their holdings of no more than 2% of the company’s shares
According to the announcement of Hangzhou Arcvideo Technology Co.Ltd(688039) , the shareholders Beijing Enlight Media Co.Ltd(300251) holding 7.86% of the shares plan to reduce the number of shares of the company by means of centralized bidding transaction and / or block transaction, which accounts for no more than 1606330 shares, accounting for no more than 2% of the total share capital of the company.
Eging Photovoltaic Technology Co.Ltd(600537) it is proposed to raise no more than 1.3 billion yuan from the controlling shareholder
Eging Photovoltaic Technology Co.Ltd(600537) announced that the company plans to issue shares in a non-public manner to qinchengda investment, the controlling shareholder, at an issue price of 3.70 yuan / share, with a fund-raising of no more than 1302.4 million yuan. The net fund-raising after deducting the issuance expenses is intended to be used for Changzhou annual 5GW efficient Cecep Solar Energy Co.Ltd(000591) component construction project, supplement working capital and repay interest bearing liabilities.
Shanghai Aj Group Co.Ltd(600643) it is proposed to transfer 10% shares of Huagui life with RMB 128 million
Shanghai Aj Group Co.Ltd(600643) announced that the company plans to transfer 100 million shares of Huagui Life Insurance Co., Ltd. for 128 million yuan, accounting for 10% of its total share capital. This transaction can further enrich the company’s financial business sector, supplement the company’s financial business structure and improve the company’s financial business chain.
Eastroc Beverage (Group) Co.Ltd(605499) pre increase of net profit in 2021 by 42% – 54%
Eastroc Beverage (Group) Co.Ltd(605499) release performance forecast. In 2021, the net profit attributable to the shareholders of the listed company is expected to be between 1150 million yuan and 1250 million yuan, with a year-on-year increase of 41.61% to 53.93%. During the reporting period, through Wuxi Online Offline Communication Information Technology Co.Ltd(300959) multi-dimensional promotion, the company continued to win the trust and repurchase of consumers, and the sales revenue of the company in 2021 increased significantly compared with the same period of last year.
Zhejiang Huayou Cobalt Co.Ltd(603799) the application for public issuance of convertible bonds was approved
According to the announcement of Zhejiang Huayou Cobalt Co.Ltd(603799) , on January 17, 2022, the development and Examination Commission of CSRC reviewed the company’s application for public issuance of convertible bonds. According to the audit results, the company’s application for public issuance of convertible bonds was approved.
Shandong Jiangquan Industry Co.Ltd(600212) it is proposed to sell the thermal power business asset group and withdraw from the thermal power business
Shandong Jiangquan Industry Co.Ltd(600212) it is announced that the company plans to transfer the thermoelectric business asset group owned by the company to Linyi Xuyuan Investment Co., Ltd. in cash. After the completion of this transaction, the listed company will strategically withdraw from the thermal power business, concentrate resources on strategic and business transformation, and focus on the business layout focusing on new energy charging and energy storage business.
Cecep Wind-Power Corporation(601016) it is proposed to invest 320 million yuan in the construction of China energy conservation Subei MAZONGSHAN 50MW wind power project
Cecep Wind-Power Corporation(601016) it is announced that the company plans to invest in the establishment of a wholly-owned subsidiary, cecep Xiangyang Wind Power Generation Co., Ltd., to build cecep Subei MAZONGSHAN 50MW wind power project, with an investment amount of 321294000 yuan.
Sailun Group Co.Ltd(601058) it is proposed to issue convertible bonds of no more than RMB 2.06 billion
Sailun Group Co.Ltd(601058) it is announced that the company plans to publicly issue convertible bonds with a fund-raising of no more than 2.06 billion yuan. After deducting the issuance expenses, it will be used for the annual output of 3 million sets of semi steel radial tires, 1 million sets of all steel radial tires and 50000 tons of off-road tires in Vietnam and 9 million sets of semi steel radial tires in Cambodia.
Qibu Corporation Limited(603557) was filed by the CSRC on suspicion of violation of laws and regulations by xinphi
Qibu Corporation Limited(603557) announced that the CSRC decided to file a case against the company because the company was suspected of violating laws and regulations in information disclosure.
Amlogic (Shanghai) Co.Ltd(688099) advance increase of net profit in 2021 by 579% – 631%
According to the announcement of Amlogic (Shanghai) Co.Ltd(688099) , it is expected to achieve an operating revenue of RMB 4740 million to RMB 4790 million in 2021, with a year-on-year increase of 73.10% to 74.93%. It is estimated that the net profit attributable to the owners of the parent company will reach 780 million yuan to 840 million yuan in 2021, with a year-on-year increase of 579.24% to 631.49%. In 2021, the shipments of intelligent set-top box chips and AI audio and video system terminal chips increased rapidly, and the company’s operating revenue exceeded 4.7 billion yuan. In the fourth quarter of 2021, the single quarter revenue exceeded 1.5 billion yuan. The annual net profit increased significantly.
Chimin Health Management Co.Ltd(603222) pre profit of 140 million – 155 million yuan in 2021
Chimin Health Management Co.Ltd(603222) release performance forecast. The company expects the net profit attributable to the shareholders of the listed company in 2021 to be 140 million yuan – 155 million yuan, an increase of 133.6028 million yuan – 148.6028 million yuan compared with the same period of the previous year. Compared with the previous year, the net profit of the company increased significantly this year, mainly due to the low scale of net profit due to the provision of goodwill impairment and litigation losses in the previous year; Second, the company’s safety syringe business increased significantly this year; Third, the company recognized the investment income from the disposal of Yuncheng new friendship hospital, and Ezhou No. 2 hospital offset part of the litigation losses accrued in the early stage.
Shanghai Longyun Cultural Creation & Technology Group Co.Ltd(603729) Zhuo Shuying, the shareholder, plans to increase her shareholding in the company
Shanghai Longyun Cultural Creation & Technology Group Co.Ltd(603729) it is announced that Zhuo Shuying, the shareholder holding more than 5% of the company, and Zhuo Guangming and Zhuo Yinan, the persons acting in concert, plan to increase their holdings of the company’s shares by means of centralized bidding trading within 12 months from the date of disclosure of this announcement, which shall not be less than 1% of the total share capital of the company. There is no price range for this increase, and the increase plan will be gradually implemented according to the fluctuation of the company’s stock price and the overall trend of the capital market.
Jiangxi Jovo Energy Co.Ltd(605090) it is planned to acquire 100% equity of Yuanfeng Sentai for no more than RMB 1.8 billion, and the trading will be resumed on the 18th
Jiangxi Jovo Energy Co.Ltd(605090) announced that the company plans to purchase 100% shares of Sichuan Yuanfeng Sentai Energy Group Co., Ltd. by issuing shares, convertible corporate bonds and paying cash, with a transaction price of no more than 1.8 billion yuan. The issue price of this transaction is determined as 32.20 yuan / share. Meanwhile, the listed company plans to issue convertible bonds to no more than 35 specific investors to raise supporting funds. The main business income of the subject company is mainly the LNG sales income of the liquefaction plant and the LNG sales income of the gas station. LNG plants are mainly distributed in Sichuan and Inner Mongolia. The trading of the company’s shares will resume from the opening of the market on January 18, 2022.
Frontier Biotechnologies Inc(688221) : the product under development fb2001 is intended to treat hospitalized patients with moderate and severe covid-19 pneumonia
Frontier Biotechnologies Inc(688221) publish the announcement of stock trading changes. The company’s product fb2001 under development is a covid-19 pneumonia virus protease inhibitor for injection, and the target is covid-19 pneumonia virus 3CL main protease. As of the disclosure date of this announcement, Pfizer’s oral covid-19 drug (paxlovid) has been authorized by the U.S. Food and Drug Administration (FDA) for emergency use to treat patients with adverse prognosis risk For non hospitalized patients with mild to moderate covid-19 pneumonia, the company’s product fb2001 is a protease inhibitor for injection, which is intended to treat hospitalized patients with moderate and severe covid-19 pneumonia; At present, the drugs approved for the treatment of hospitalized patients with covid-19 pneumonia include remdesivir of Gilead company.
Please make rational decisions and invest prudently.
Henan Mingtai Al.Industrial Co.Ltd(601677) the net profit in 2021 is expected to increase by 73% – 82%
Henan Mingtai Al.Industrial Co.Ltd(601677) release performance forecast. It is estimated that the net profit attributable to the shareholders of the listed company will reach 1.85 billion yuan to 1.95 billion yuan in 2021, with a year-on-year increase of 73% to 82%. During the reporting period, the company completed the sales volume of 1.18 million tons of aluminum sector, strip and foil, an increase of about 210000 tons over the previous year, a year-on-year increase of about 21%, continuing the continuous growth momentum of production and sales, and continuously improving the market share and industry influence.
Qingdao Victall Railway Co.Ltd(605001) shareholders plan to reduce their holdings of no more than 2% of the company’s shares
Qingdao Victall Railway Co.Ltd(605001) it is announced that the shareholder Ningbo jiuying plans to reduce the shares of all its companies by means of centralized competitive bidding within 6 months after 3 trading days from the date of announcement, and the reduction proportion shall not exceed 2% of the total shares of the company.
Baotailong New Materials Co.Ltd(601011) pre increase of net profit in 2021 by 171% – 208%
Baotailong New Materials Co.Ltd(601011) release performance forecast. It is estimated that the net profit attributable to the shareholders of the listed company will reach 145 million yuan to 165 million yuan in 2021, with a year-on-year increase of 170.76% to 208.10%. In 2021, the prosperity of the coking industry was better, the sales price of the company’s main products increased significantly year-on-year, and the comparison base of the previous year was small.
Shanghai Zj Bio-Tech Co.Ltd(688317) shareholders plan to reduce their total holdings of no more than 6% of the company’s shares
Shanghai Zj Bio-Tech Co.Ltd(688317) it is announced that Panxin investment, the shareholder of the company, plans to reduce its shares of the company by means of centralized bidding, which shall not exceed 5% of the total shares of the company. The reduction period is within six months after 15 trading days from the date of disclosure of this announcement. Ningbo ruidao, the shareholder of the company, plans to reduce the shares of the company by means of centralized bidding, which shall not exceed 1% of the total shares of the company. The reduction period is within three months after 15 trading days from the date of disclosure of this announcement.
Shanghai Jahwa United Co.Ltd(600315) net profit increased by 52% in 2021 and 99% in the fourth quarter
Shanghai Jahwa United Co.Ltd(600315) release performance forecast. It is estimated that the net profit attributable to the shareholders of the listed company will be about 655 million yuan in 2021, with a year-on-year increase of about 52%. In the fourth quarter of 2021, the company expects to realize a net profit attributable to the shareholders of the listed company of about 235 million yuan, an increase of about 99% year-on-year. During the reporting period, the company adhered to the differentiated brand development strategy, and skin care category, as a high gross profit and rapid development category positioned by the company, achieved rapid growth.
Sichuan Em Technology Co.Ltd(601208) the net profit in 2021 will increase by 100% – 117%
Sichuan Em Technology Co.Ltd(601208) release performance forecast. The company expects to realize the net profit attributable to the shareholders of the listed company in 2021, which will increase by about 175 million yuan to 205 million yuan compared with the same period of the previous year, with a year-on-year increase of about 99.72% to 116.81%. During the reporting period, China’s procurement costs and regional supporting advantages were gradually highlighted, the localization process of core raw materials was significantly accelerated, and the company’s overall sales scale and comprehensive profitability were effectively improved.
Shanghai Construction Group Co.Ltd(600170) clarification: there are errors in some contents of relevant media reports
Shanghai Construction Group Co.Ltd(600170) issued a Clarification Announcement. Recently, some media published an article on the Internet entitled Shanghai Construction Group Co.Ltd(600170) the newly signed contract amount in 2021 increased by 14.4% year-on-year, and the total debt was nearly 1.1 trillion by the end of the third quarter. After verification, there are errors in some contents of the above report. In order to avoid misleading investors, the company hereby clarifies that as of the end of the third quarter of 2021, the company’s total assets were 339.692 billion yuan, including 264.104 billion yuan of current assets and 75.588 billion yuan of non current assets; Total liabilities are 289.371 billion yuan, including current liabilities of 219.918 billion yuan and non current liabilities of 69.453 billion yuan. At present, Shanghai Construction Group Co.Ltd(600170) (Group) head office holds 30.19% of the shares of the company, and Shanghai Guosheng (Group) Co., Ltd. holds 19.88% of the shares of the company.
Longyan Zhuoyue New Energy Co.Ltd(688196) performance express: net profit in 2021 increased by 44% year-on-year
Longyan Zhuoyue New Energy Co.Ltd(688196) release performance express. In 2021, the company realized an operating revenue of 3.077 billion yuan, an increase of 92.49% over the previous year; The net profit attributable to the parent company was 349 million yuan, an increase of 44.09% over the previous year. The main reason is that the newly-built biodiesel project with an annual output of 100000 tons in Meishan plant of the company has reached the production on schedule, and other plants have reached full production, resulting in a significant increase in the production and sales of biodiesel.
Shuangliang Eco-Energy Systems Co.Ltd(600481) single crystal silicon wafer sales contract signed, with an estimated amount of 6.3 billion yuan
Shuangliang Eco-Energy Systems Co.Ltd(600481) announced that the wholly-owned subsidiary Shuangliang silicon materials (Baotou) Co., Ltd. (hereinafter referred to as “the seller”) signed the silicon wafer procurement framework contract with Tongwei Cecep Solar Energy Co.Ltd(000591) (Chengdu) Co., Ltd. (hereinafter referred to as “the buyer”) on January 17, 2022. The contract stipulates that from January 2022 to December 2024, the buyer expects to purchase a total of 1048 million monocrystalline silicon wafers (including 210mm and 182mm specifications) from the seller. Single crystal silicon wafer (210mm / 160) according to the latest statistics of PV InfoLink (January 12, 2022) μ m) And monocrystalline silicon wafer (182mm / 165 μ m) According to the average price calculation, the total sales amount from 2022 to 2024 is expected to be 6.305 billion yuan (including tax).
Shandong Fiberglass Group Co.Ltd(605006) shareholders plan to reduce their holdings of no more than 2% of the company’s shares
Shandong Fiberglass Group Co.Ltd(605006) announcement: Dongfang Bangxin, a shareholder holding 15.24% of the shares, intends to reduce the number of shares not exceeding 10000000 (i.e. not exceeding 2% of the total share capital of the company) through centralized bidding within 6 months after 15 trading days from the date of disclosure of this announcement.
Add Industry(Zhejiang) Co.Ltd(603089) the wholly-owned subsidiary returned to work and production in an orderly manner
Add Industry(Zhejiang) Co.Ltd(603089) announced that at present, the epidemic prevention and control in Beilun District of Ningbo has achieved phased results, and the area where Ningbo Hongyu, a wholly-owned subsidiary of the company, is located has been lifted. Ningbo Hongyu began to resume work and production orderly from January 17, 2022, and implemented comprehensive prevention and control measures to ensure the health of employees and the normal operation of the company.
Xinjiang Tianye Co.Ltd(600075) the net profit in 2021 will increase by 80% – 97%
Xinjiang Tianye Co.Ltd(600075) release performance forecast. The net profit attributable to the shareholders of the listed company in 2021 is expected to be RMB 160 million to RMB 175 million, with a year-on-year increase of 80% to 97%. In 2021, due to the sharp rise in the market prices of PVC resin, caustic soda and other products, as well as the merger and acquisition of subsidiaries under the same control, the company’s operating profit margin and net profit increased significantly year-on-year.
Wanhua Chemical Group Co.Ltd(600309) pre increase of net profit in 2021 by 139% – 151%
Wanhua Chemical Group Co.Ltd(600309) release performance forecast. It is estimated that the net profit attributable to the shareholders of the listed company will be 24 billion yuan to 25.2 billion yuan in 2021, with a year-on-year increase of 139% to 151%. During the reporting period, the market demand was boosted and the price of chemical products increased. The company’s MDI technical transformation, ethylene and other new production capacity and new devices were put into operation, the volume and price of major products such as polyurethane, petrochemical and fine chemicals increased simultaneously, and the operating performance increased significantly year-on-year.
Bros Eastern Co.Ltd(601339) net profit in 2021 will increase by 263% – 280%
Bros Eastern Co.Ltd(601339) release performance forecast. It is estimated that the net profit attributable to the shareholders of the listed company will reach 1.33 billion yuan to 1.39 billion yuan in 2021, with a year-on-year increase of 263% to 280%. The expected increase of the company’s performance is mainly due to the comprehensive impact of factors such as the recovery of the company’s overall production capacity to the pre epidemic level in 2021, the improvement of production capacity utilization, the increase of orders, the growth of main business profits and so on.
Hangzhou Lion Electronics Co.Ltd(605358) advance increase of net profit in 2021 192% – 217%
Hangzhou Lion Electronics Co.Ltd(605358) release performance forecast. The company expects the net profit attributable to the shareholders of the listed company to be RMB 59 million to RMB 64 million in 2021, with a year-on-year increase of 192.14% to 216.90%. During the reporting period, the benefits of production scale increased significantly. The company’s production lines are operating at full capacity, sales orders are full, and the production and sales of main products have increased significantly.
Nanjing Tanker Corporation(601975) shareholders plan to reduce their holdings of no more than 2% of the company’s shares
Nanjing Tanker Corporation(601975) announcement: CCB Jiangsu Branch, the shareholder holding 7.50%, plans to reduce the company’s shares by centralized bidding within 6 months after 15 trading days from the date of disclosure of this announcement, which shall not exceed 2% of the company’s total share capital.
Zhejiang Conba Pharmaceutical Co.Ltd(600572) parecoxib sodium for injection passed the conformity evaluation of generic drugs
According to the announcement of Zhejiang Conba Pharmaceutical Co.Ltd(600572) , Jinhua Zhejiang Conba Pharmaceutical Co.Ltd(600572) , the holding subsidiary of the company, received the notice of approval for supplementary drug application for parecoxib sodium for injection issued by the State Food and drug administration, and the drug passed the conformity evaluation of generic drugs. Parecoxib sodium for injection is suitable for short-term treatment of postoperative pain. It plays an anti-inflammatory and analgesic role by specifically inhibiting COX-2 and blocking the synthesis of prostaglandins by arachidonic acid, and can reduce the dosage of narcotic analgesics.
